AP2012006119A0 - Pharmaceutical composition of isoniazid. - Google Patents
Pharmaceutical composition of isoniazid.Info
- Publication number
- AP2012006119A0 AP2012006119A0 AP2012006119A AP2012006119A AP2012006119A0 AP 2012006119 A0 AP2012006119 A0 AP 2012006119A0 AP 2012006119 A AP2012006119 A AP 2012006119A AP 2012006119 A AP2012006119 A AP 2012006119A AP 2012006119 A0 AP2012006119 A0 AP 2012006119A0
- Authority
- AP
- ARIPO
- Prior art keywords
- isoniazid
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- 229960003350 isoniazid Drugs 0.000 title 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical group NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1765MU2009 | 2009-07-31 | ||
| IN1991MU2009 | 2009-09-01 | ||
| PCT/IB2010/001871 WO2011012987A1 (en) | 2009-07-31 | 2010-07-29 | Pharmaceutical composition of isoniazid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2012006119A0 true AP2012006119A0 (en) | 2012-02-29 |
Family
ID=43528828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2012006119A AP2012006119A0 (en) | 2009-07-31 | 2010-07-29 | Pharmaceutical composition of isoniazid. |
Country Status (4)
| Country | Link |
|---|---|
| AP (1) | AP2012006119A0 (en) |
| RU (1) | RU2012105674A (en) |
| WO (1) | WO2011012987A1 (en) |
| ZA (1) | ZA201200659B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2672879C2 (en) | 2013-07-26 | 2018-11-20 | Санофи | Antitubercular composition comprising rifampicin, isoniazid, ethambutol and pyrazinamide and process for preparation thereof |
| HK1218861A1 (en) * | 2013-07-26 | 2017-03-17 | Sanofi | Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation |
| EP3773731A1 (en) | 2018-04-05 | 2021-02-17 | Cipla Limited | Pharmaceutical formulations |
| CN112438951A (en) * | 2019-08-28 | 2021-03-05 | 重庆华邦制药有限公司 | Method for preparing isoniazid preparation and preparation thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0650728B1 (en) * | 1993-10-29 | 2002-02-27 | Council of Scientific and Industrial Research | Pharmaceutical compositions containing piperine and an antituberculosis or antileprosydrug |
| MXPA02003596A (en) * | 2000-08-09 | 2003-10-14 | Panacea Biotec Ltd | Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation. |
-
2010
- 2010-07-29 AP AP2012006119A patent/AP2012006119A0/en unknown
- 2010-07-29 RU RU2012105674/15A patent/RU2012105674A/en unknown
- 2010-07-29 WO PCT/IB2010/001871 patent/WO2011012987A1/en not_active Ceased
-
2012
- 2012-01-26 ZA ZA2012/00659A patent/ZA201200659B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2012105674A (en) | 2013-09-10 |
| ZA201200659B (en) | 2012-10-31 |
| WO2011012987A1 (en) | 2011-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL215451A0 (en) | Pharmaceutical composition | |
| ZA201108697B (en) | Quinoline derivatives-containing pharmaceutical composition | |
| SG2014012462A (en) | Pharmaceutical compositions | |
| PL3246018T3 (en) | Pharmaceutical composition | |
| EP2379077A4 (en) | Pharmaceutical composition | |
| SMT201700008T1 (en) | Pharmaceutical composition | |
| ZA201207375B (en) | Stabilized pharmaceutical composition | |
| ZA201104670B (en) | Pharmaceutical composition comprising aleglitazar | |
| PL2298090T3 (en) | Pharmaceutical or nutraceutical composition | |
| AP2012006119A0 (en) | Pharmaceutical composition of isoniazid. | |
| GB0902648D0 (en) | Pharmaceutical compounds and compositions | |
| IL219018A0 (en) | Pharmaceutical compositions | |
| GB201001911D0 (en) | Pharmaceutical composition | |
| GB0919650D0 (en) | Pharmaceutical composition | |
| GB0908317D0 (en) | Pharmaceutical compounds and compositions | |
| AP2012006117A0 (en) | Pharmaceutical composition of rifampicin. | |
| HU0900010D0 (en) | Improved pharmaceutical composition | |
| GB0901241D0 (en) | Pharmaceutical compositions | |
| HU1000006D0 (en) | Improved pharmaceutical composition | |
| GB0908970D0 (en) | Local pharmaceutical compositions | |
| GB0902428D0 (en) | Pharmaceutical methods & compositions | |
| GB0921139D0 (en) | Pharmaceutical methods & compositions | |
| HU0800741D0 (en) | Improved pharmaceutical composition | |
| GB0903945D0 (en) | Pharmaceutical compounds and compositions | |
| GB0919055D0 (en) | Pharmaceutical compounds and compositions |